These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 2912561
1. Comparison of DNA-protein cross-links induced by 4'-(9-acridinylamino)-methanesulfon-m-anisidide and by gamma-radiation. Chiu SM, Xue LY, Friedman LR, Oleinick NL. Cancer Res; 1989 Feb 15; 49(4):910-4. PubMed ID: 2912561 [Abstract] [Full Text] [Related]
4. Production of protein-associated DNA breaks by 10-[diethylaminopropylamino]-6-methyl-5H-pyrido[3',4':4,5]pyrrolo [2,3-g]isoquinoline in cultured L1210 cells and in isolated nuclei: comparison with other topoisomerase II inhibitors. Pierson V, Pierre A, Pommier Y, Gros P. Cancer Res; 1988 Mar 15; 48(6):1404-9. PubMed ID: 2830964 [Abstract] [Full Text] [Related]
5. Topoisomerase II-mediated DNA breaks and cytotoxicity in relation to cell proliferation and the cell cycle in NIH 3T3 fibroblasts and L1210 leukemia cells. Markovits J, Pommier Y, Kerrigan D, Covey JM, Tilchen EJ, Kohn KW. Cancer Res; 1987 Apr 15; 47(8):2050-5. PubMed ID: 3030540 [Abstract] [Full Text] [Related]
6. Effect of cell proliferation and chromatin conformation on intercalator-induced, protein-associated DNA cleavage in human brain tumor cells and human fibroblasts. Zwelling LA, Estey E, Silberman L, Doyle S, Hittelman W. Cancer Res; 1987 Jan 01; 47(1):251-7. PubMed ID: 3024817 [Abstract] [Full Text] [Related]
7. Protein-linked DNA strand breaks induced in mammalian cells by camptothecin, an inhibitor of topoisomerase I. Covey JM, Jaxel C, Kohn KW, Pommier Y. Cancer Res; 1989 Sep 15; 49(18):5016-22. PubMed ID: 2548707 [Abstract] [Full Text] [Related]
8. Topoisomerase II mediated DNA lesions induced by acridine-4-carboxamide and 2-(4-pyridyl)quinoline-8-carboxamide. Woynarowski JM, McCarthy K, Reynolds B, Beerman TA, Denny WA. Anticancer Drug Des; 1994 Feb 15; 9(1):9-24. PubMed ID: 8141968 [Abstract] [Full Text] [Related]
9. Dual topoisomerase I and II inhibition by intoplicine (RP-60475), a new antitumor agent in early clinical trials. Poddevin B, Riou JF, Lavelle F, Pommier Y. Mol Pharmacol; 1993 Oct 15; 44(4):767-74. PubMed ID: 8232227 [Abstract] [Full Text] [Related]
10. Mechanism of resistance of noncycling mammalian cells to 4'-(9-acridinylamino)methanesulfon-m-anisidide: comparison of uptake, metabolism, and DNA breakage in log- and plateau-phase Chinese hamster fibroblast cell cultures. Robbie MA, Baguley BC, Denny WA, Gavin JB, Wilson WR. Cancer Res; 1988 Jan 15; 48(2):310-9. PubMed ID: 2825971 [Abstract] [Full Text] [Related]
11. Topoisomerase II as a target of VM-26 and 4'-(9-acridinylamino)methanesulfon-m-aniside in atypical multidrug resistant human small cell lung carcinoma cells. de Jong S, Kooistra AJ, de Vries EG, Mulder NH, Zijlstra JG. Cancer Res; 1993 Mar 01; 53(5):1064-71. PubMed ID: 8382551 [Abstract] [Full Text] [Related]
12. Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells. Minford J, Kerrigan D, Nichols M, Shackney S, Zwelling LA. Cancer Res; 1984 Dec 01; 44(12 Pt 1):5583-93. PubMed ID: 6208999 [Abstract] [Full Text] [Related]
13. Yield of DNA-protein cross-links in gamma-irradiated Chinese hamster cells. Ramakrishnan N, Chiu SM, Oteinick NL. Cancer Res; 1987 Apr 15; 47(8):2032-5. PubMed ID: 3828991 [Abstract] [Full Text] [Related]
14. Cytotoxicity and DNA strand breaks by 5-iminodaunorubicin in mouse leukemia L1210 cells: comparison with adriamycin and 4'-(9-acridinylamino)methanesulfon-m-anisidide. Zwelling LA, Kerrigan D, Michaels S. Cancer Res; 1982 Jul 15; 42(7):2687-91. PubMed ID: 6896293 [Abstract] [Full Text] [Related]
15. In vitro toxicity and DNA cleaving capacity of benzisoquinolinedione (nafidimide; NSC 308847) in human leukemia. Andersson BS, Beran M, Bakic M, Silberman LE, Newman RA, Zwelling LA. Cancer Res; 1987 Feb 15; 47(4):1040-4. PubMed ID: 3026621 [Abstract] [Full Text] [Related]
16. Formation and repair of DNA-protein crosslinks in newly replicated DNA. Chiu SM, Friedman LR, Oleinick NL. Radiat Res; 1989 Dec 15; 120(3):545-51. PubMed ID: 2594973 [Abstract] [Full Text] [Related]
17. Effect of cellular ATP depletion on topoisomerase II poisons. Abrogation Of cleavable-complex formation by etoposide but not by amsacrine. Sorensen M, Sehested M, Jensen PB. Mol Pharmacol; 1999 Mar 15; 55(3):424-31. PubMed ID: 10051525 [Abstract] [Full Text] [Related]
18. Protein-associated deoxyribonucleic acid strand breaks in L1210 cells treated with the deoxyribonucleic acid intercalating agents 4'-(9-acridinylamino) methanesulfon-m-anisidide and adriamycin. Zwelling LA, Michaels S, Erickson LC, Ungerleider RS, Nichols M, Kohn KW. Biochemistry; 1981 Nov 10; 20(23):6553-63. PubMed ID: 6895473 [Abstract] [Full Text] [Related]
19. Repair of chromatin damage in glutathione-depleted V-79 cells: comparison of oxic and hypoxic conditions. Xue LY, Friedman LR, Oleinick NL. Radiat Res; 1988 Oct 10; 116(1):89-99. PubMed ID: 3186930 [Abstract] [Full Text] [Related]
20. Characterisation of cytotoxicity and DNA damage induced by the topoisomerase II-directed bisdioxopiperazine anti-cancer agent ICRF-187 (dexrazoxane) in yeast and mammalian cells. Jensen LH, Dejligbjerg M, Hansen LT, Grauslund M, Jensen PB, Sehested M. BMC Pharmacol; 2004 Dec 02; 4():31. PubMed ID: 15575955 [Abstract] [Full Text] [Related] Page: [Next] [New Search]